When will Gadoterate Meglumine Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Gadoterate Meglumine Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Gadoterate Meglumine Injection

Brand names: Gadoterate Meglumine

Category: Medical Imaging

Not specified 4

FDA status: To Be Discontinued · Last FDA update: Jun 30, 2026 · First posted: May 21, 2026 · 1 manufacturers, 4 listed presentations

As of Jun 30, 2026, the FDA lists Gadoterate Meglumine Injection as being discontinued. Of 4 manufacturer presentations, 4 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Gadoterate Meglumine Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) NDC 65219-084-15	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	Not specified	Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) NDC 65219-080-05	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	Not specified	Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) NDC 65219-082-10	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	Not specified	Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) NDC 65219-086-20	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	Not specified	Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug

Related medications in shortage

Other Medical Imaging medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Gadoterate Meglumine Injection (FDA data as of Jun 30, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Gadoterate Meglumine Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Gadoterate Meglumine Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/gadoterate-meglumine-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).